Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade
- 30 June 1995
- journal article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 25 (6), 954-966
- https://doi.org/10.1016/0272-6386(95)90582-0
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- P80 form of the human tumor necrosis factor receptor is involved in DNA fragmentationFEBS Letters, 1993
- Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodiesCritical Care Medicine, 1993
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993
- Downmodulation of c-myc expression by interferon γ and tumour necrosis factor α precedes growth arrest in human melanoma cellsEuropean Journal of Cancer, 1992
- Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues.The Journal of Experimental Medicine, 1992
- Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant P60 and P80 receptorsBiochemical and Biophysical Research Communications, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Autoantibodies to cytokines - friends or foes?Immunology Today, 1990
- There is more than one interleukin 1Immunology Today, 1986